PlainRecalls
FDA Devices Critical Class I Ongoing

Obsidio Conformable Embolic, Material Numbers (UPN): a) M0013972001010, b) M0013972101010

Reported: April 3, 2024 Initiated: February 20, 2024 #Z-1374-2024

Product Description

Obsidio Conformable Embolic, Material Numbers (UPN): a) M0013972001010, b) M0013972101010

Reason for Recall

An investigation determined that delivery of the Obsidio embolic using the aliquot technique for lower gastrointestinal bleeding embolization poses a high risk of bowel ischemia. The most serious and the most common adverse health consequence, reasonably foreseeable to occur, is the need to perform major surgery such as bowel resection and/or diverting colostomy. Therefore, Boston Scientific does not recommend that the aliquot technique be used to deliver the Obsidio device for lower GI bleed embolization procedures.

Details

Units Affected
985 units
Distribution
US
Location
Maple Grove, MN

Frequently Asked Questions

What product was recalled?
Obsidio Conformable Embolic, Material Numbers (UPN): a) M0013972001010, b) M0013972101010. Recalled by Boston Scientific Corporation. Units affected: 985 units.
Why was this product recalled?
An investigation determined that delivery of the Obsidio embolic using the aliquot technique for lower gastrointestinal bleeding embolization poses a high risk of bowel ischemia. The most serious and the most common adverse health consequence, reasonably foreseeable to occur, is the need to perform major surgery such as bowel resection and/or diverting colostomy. Therefore, Boston Scientific does not recommend that the aliquot technique be used to deliver the Obsidio device for lower GI bleed embolization procedures.
Which agency issued this recall?
This recall was issued by the FDA Devices on April 3, 2024. Severity: Critical. Recall number: Z-1374-2024.